Cargando…
Intraocular pressure effect of intravitreal conbercept injection for retinopathy of prematurity
Purpose: Intravitreal injection of conbercept (IVC) is a novel anti-vascular endothelial growth factor (anti-VEGF) treatment for retinopathy of prematurity (ROP). This study aimed to assess the intraocular pressure (IOP) effect of IVC. Methods: All IVC surgeries were performed in the Department of O...
Autores principales: | Gao, Caifeng, Mu, Ge, Zhao, Huanhuan, Zheng, Jiao, Feng, Qingyang, Wu, Yining, Li, Yinan, Huang, Xuelin, Sun, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266213/ https://www.ncbi.nlm.nih.gov/pubmed/37324456 http://dx.doi.org/10.3389/fphar.2023.1165356 |
Ejemplares similares
-
Evaluation of short-term intraocular pressure changes after intravitreal injection of Conbercept in patients with diabetic macular edema
por: Hu, Yunyan, et al.
Publicado: (2022) -
A lower dose of intravitreal conbercept effectively treats retinopathy of prematurity
por: Cheng, Yong, et al.
Publicado: (2018) -
Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity
por: Obata, Shumpei, et al.
Publicado: (2019) -
Network meta-analysis of intravitreal conbercept as an adjuvant to vitrectomy for proliferative diabetic retinopathy
por: Wang, Weiwei, et al.
Publicado: (2023) -
Efficacy of intravitreal injection of conbercept on non-proliferative diabetic retinopathy: a retrospective study
por: Wang, Jing, et al.
Publicado: (2020)